Kelyniam's CEO Addresses Shareholders
March 16 2010 - 8:00AM
Marketwired
Kelyniam Global, Inc. (PINKSHEETS: KLYG) announces today that the
company's CEO, Mr. James Ketner, has recently given an update on
the company's current status to the shareholders. The following are
excerpts from the Shareholder update.
"In the month of February alone we have made the most
significant advancements in accomplishing our pursuit of entering
the medical discipline. There are still a few more hurdles to
overcome in this arena but we are confident that these obstacles
will be resolved in the next couple months, hopefully sooner. We
have purchase orders in place with some big hospitals, and are
currently scheduled for operations utilizing Kelyniam's Custom
Cranial Implants. If these first operations are successful, then we
are entering a market with some very large competitors.
Our current capacity to manufacture any type of implant is about
1,500 units per year, and with our current pricing, we are
estimating about 4.5 million in revenues if we reach full capacity.
We can double that capacity in about two months if necessary, so
there is really not any limitation on what we can produce. We have
the latest state of the art equipment to meet these needs, and the
talent to operate this equipment.
We recently teamed up with the sales force at Synergy Surgical.
The guys at Synergy are young and aggressive and will be diligently
promoting our implant products. They work on the weekend, holidays,
whatever it takes to get the job done, and that to me is
impressive. We do the same over here at Kelyniam, doesn't matter if
it is Saturday, Sunday, holiday, if something needs to be done, we
are here to tackle the problem or meet schedule.
We are currently investigating moving our engineering
manufacturing facility in Connecticut and combining the corporate
office with the engineering division to increase efficiency and to
reduce operating cost. I am currently in favor of moving this to
the city of Little Rock. The other consideration is moving both the
corporate and the engineering division to the North Carolina
research triangle in the Raleigh-Durham and Chapel Hill area. The
decision will be made on the most favorable options the State of
Arkansas will offer and the State of North Carolina.
Last year, we regretfully lost the employ of Ms. Michelle LynRay
and have not found a replacement for her role. After several
attempts at her replacement, we are still pursuing the accountant
position vacancy. She was a huge asset to the company and her
constant professionalism and diligence along with her friendship
and perspective will be greatly missed.
Kelyniam is not pursing the MRI centers since the director that
was going to handle that project has left the company. Kelyniam has
not, or will not be raising money for the MRI centers by selling
stock in the open market or by selling to private investors.
Again, these are some things that would be important to me if I
were considering investing in a small startup company like ours.
There are some great risks involved with investing in our company
stock, and these risks should be considered before doing so."
James Ketner President/CEO
The entire letter can be found by going to the company website
and selecting the link investor relations, or by following this
link, www.kelyniam.com/investor_relations.asp
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: James Ketner President/CEO Kelyniam Global, Inc.
www.kelyniam.com 1-800-280-8192
Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From Oct 2023 to Oct 2024